Williams-Sonoma Earnings Beat, Raises Outlook

Williams-Sonoma earnings beat Q2 estimates as an IEEPA tariff refund lifted GAAP margins; the raised guidance supported near-term investor sentiment.

August 26, 2026·2 min read
View all news articles
Flat vector of an armchair revealing a ledger, symbolizing Williams-Sonoma earnings, tariff refund and margin divergence.

KEY TAKEAWAYS

  • Revenue growth accelerated and comparable brand sales strengthened.
  • An IEEPA tariff refund boosted GAAP margins while non-GAAP margins showed pressure.
  • Management raised full-year revenue and non-GAAP margin guidance while liquidity remained ample.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Williams-Sonoma, Inc. (NYSE: WSM) reported fiscal second-quarter 2026 earnings on Aug. 26 that exceeded estimates, prompting the company to raise its full-year revenue and margin guidance. Management attributed the results to broad-based brand strength and a one-time tariff refund that boosted GAAP margins.

Quarter Results and Margins

For the 13 weeks ended Aug. 2, 2026, Williams-Sonoma reported net revenues of about $1.96 billion, up 6.7% year over year. Comparable brand revenue rose 6.2%, accelerating from the first quarter. Pottery Barn generated approximately $770.8 million, and West Elm contributed about $496.3 million, together accounting for nearly two-thirds of net revenues. The company described the quarter as “very strong.”

GAAP gross margin expanded to 51.6%, an increase of roughly 450 basis points from the prior year, driven primarily by a $167.8 million reduction in cost of goods sold related to a refund of tariffs imposed under the International Emergency Economic Powers Act (IEEPA). The company collected nearly all of an initial $197.8 million claim, leaving a receivable of about $3.2 million as of Aug. 2. These tariff refunds and related items are excluded from non-GAAP results.

Excluding the tariff refund, non-GAAP gross margin declined about 160 basis points to 45.5%, reflecting tighter merchandise margins. GAAP operating income was about $449 million, producing a 22.9% operating margin, up roughly 500 basis points year over year. Non-GAAP operating income was approximately $338 million, with a 17.3% margin, down about 60 basis points from the prior year.

GAAP diluted earnings per share (EPS) rose to $2.84, up about 42% from the prior year, while non-GAAP diluted EPS increased 5.0% to $2.10. The adjusted EPS exceeded consensus estimates.

Guidance and Cash Flow

Williams-Sonoma raised its fiscal 2026 outlook, projecting net revenue growth of 4.7% to 7.2% and comparable brand revenue growth of 4.0% to 6.5%. The company also increased its non-GAAP operating margin guidance to 17.8% to 18.2%, excluding the one-time tariff refund. Management cited market-share gains in a home furnishings market described as essentially flat, along with ongoing investments in technology and supply-chain initiatives.

Liquidity remained strong, with cash and cash equivalents of about $1.03 billion at quarter-end. Operating cash flow for the 26 weeks ended Aug. 2 was approximately $695.9 million, up from $401.7 million a year earlier. Merchandise inventories rose about 1% year over year to roughly $1.45 billion, net of deferred tariff refund income. The company returned about $90 million to shareholders during the quarter through dividends.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Photronics Q3 Results Show Margin Gain, Cautious Q4

Photronics Q3 Results Show Margin Gain, Cautious Q4

Photronics Q3 results beat guidance as high-end IC demand lifted margins; trimmed capex and a wide Q4 range signal near-term positioning risk for investors.

Nvidia Earnings Test AI Demand After PCE, GDP

Nvidia Earnings Test AI Demand After PCE, GDP

Nvidia earnings will test AI-driven revenue as July PCE stayed elevated and US GDP remained modest, potentially shifting near-term market flows.

Revolution Medicines FDA Approval Clears Rasonque

Revolution Medicines FDA Approval Clears Rasonque

Revolution Medicines FDA approval cleared RASONQUE for previously treated metastatic pancreatic cancer, boosting near-term investor positioning.

Boston Scientific Cyberattack Disrupts Shipments

Boston Scientific Cyberattack Disrupts Shipments

Boston Scientific cyberattack halted order processing and shipments, creating revenue and fulfillment risk as restoration timing remains unknown.

Semtech Earnings Show Record Q2 Revenue

Semtech Earnings Show Record Q2 Revenue

Semtech earnings beat on record Q2 sales and $0.71 adjusted EPS as AI data-center demand lifts margins and firms near-term growth positioning.

Kohl's Earnings Show Profit Lift From Tariff Refunds

Kohl's Earnings Show Profit Lift From Tariff Refunds

Kohl's earnings show profit and wider margins after tariff refunds while sales slipped, lifting EPS guidance and supporting near-term buybacks and returns